17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2087 | AF-353 | Ro-4 | P2X Receptor |
AF-353 (Ro-4), an effective and orally bioavailable antagonist of the P2X3/P2X2/3 receptor, inhibits human and rat P2X3 (pIC50= 8.0). | |||
T3559 | 4-Oxoisotretinoin | Oxoretinoic acid,4-Oxoisotretinoin,Ro 22-6595 | Others |
4-Oxoisotretinoin (Ro 22-6595) is the major blood metabolite. | |||
T12745L | (4R)-RO5263397 | Others | |
(4R)-4-(3-Fluoro-2-methylphenyl)-4,5-dihydro-2-oxazolamin was active against TRACE AMINE ASSOCIATED RECEPTOR (TAAR 1) with an EC50 of 0.017 μM and could be used to study neurological disorders. | |||
T34361 | Ro 4-6824 | AI3-50843 | |
Ro 4-6824 is a biochemical with immunosuppressive action. | |||
T8139 | Sulfamethoxazole sodium | Ro 4-2130 sodium | Others , Antibacterial , Antibiotic |
Sulfamethoxazole sodium (Ro 4-2130 sodium) is a sulfonamide bacteriostatic antibiotic | |||
T1517 | Benserazide hydrochloride | Benserazide HCl,Serazide,Ro 4-4602 | Dopamine Receptor |
Benserazide hydrochloride (Ro 4-4602) is a peripherally-acting L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor. | |||
T0885 | Sulfamethoxazole | Ro 4-2130,STX 608 | Antibacterial , Antibiotic , Autophagy |
Sulfamethoxazole (STX 608) is a Sulfonamide Antimicrobial. The mechanism of action of sulfamethoxazole is as a Cytochrome P450 2C9 Inhibitor. The chemical classification of sulfamethoxazole is Sulfonamides. | |||
T14489 | Azvudine | FNC,RO-0622 | HCV Protease , HBV , HIV Protease , Reverse Transcriptase |
Azvudine (FNC) is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine inhibits NRTI-resistant viral strains. Azvudine exerts highly potent inhibition on HIV-1... | |||
T7745 | Diclofensine hydrochloride | Ro 8-4650 hydrochloride | Others , Dopamine Receptor |
Diclofensine hydrochloride (Ro 8-4650 hydrochloride) is a Novel Antidepressant, on Peripheral Adrenergic Function | |||
T19706 | Ro 20-1724 | Ro-20-1724,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,Ro20-1724 | PDE |
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone) is a widely used inhibitor of cyclic nucleotide phosphodiesterase with IC50 of 2.0 μM and Ki of 3.1 μM. | |||
T1488L | Procarbazine free base | CB 400-497,NSC-77213,Ro 4-6467/1,Ro 4-6467,Procarbazine | |
Procarbazine is an antineoplastic chemotherapy drug for the treatment of Hodgkin's lymphoma and certain brain cancers. The drug is metabolized and activated in the liver. It also inhibits MAO thus increasing the effects ... | |||
T13031 | Sulfamethoxazole-d4 | Ro 4-2130 D4 | Others |
Sulfamethoxazole D4 is a deuterium labeled Sulfamethoxazole (Ro 4-2130). Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic. | |||
T11679 | Isavuconazole-d4 | BAL-4815 D4,RO-0094815 D4,Isavuconazole D4 | Others |
Isavuconazole D4 is a deuterium labeled Isavuconazole. Isavuconazole is a triazole prodrug with antifungal activity against yeasts, molds, and dimorphic fungi. | |||
T12718 | RG7800 hydrochloride (1449598-06-4 free base) | RO6885247 hydrochloride,RG7800 hydrochloride | Others |
RG7800 hydrochloride is an orally active modulator of SMN2 splicing. | |||
T6312 | R547 | Ro 4584820 | Apoptosis , GSK-3 , PKA , CDK |
R547 (Ro 4584820) is a potent ATP-competitive inhibitor of CDK1/2/4 with Ki of 2 nM/3 nM/1 nM. It is less potent to CDK7 and GSK3α/β, while inactive to other kinases. Phase 1. | |||
T28595 | Ro-0505124 | Ro0505124,Ro 0505124 | |
Ro-0505124 is a potent, selective and ATP-competitive inhibitor of cyclin-dependent kinase 4 (CDK4). | |||
T70838 | RO27-3225 TFA | ||
RO27-3225, also known as RO273225 is a melanocortin type 4 receptor agonist with EC50 = 1 nM. It may alleviate intestinal dysfuntion and brain damage. It has been investigated for an anti-obesity medication. Ro 27-3225... |